Managers / Q3 2022 · view latest →
Lynwood Capital Management Inc.
CIK 0001846412 · 200 BAY STREET, ROYAL BANK PLAZA SOUTH TOWER, #1304, TORONTO, A6, M5J2J1 · 416-921-4511
Summary
Lynwood Capital Management Inc. reported $92M in U.S.-listed holdings across 146 positions for Q3 2022.
Its largest position, Briacell Therapeutics, represents 7.4% of the portfolio.
Compared with Q2 2022, the fund opened 21 new positions and exited 19.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 71.2% · $65M
- Common Stock · 22.5% · $21M
- ETP · 4.3% · $4M
- REIT · 1.9% · $2M
- Equity WRT · 0.0% · $14,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GDXJVANECK ETF TRUST | NEW | +100.0K | 100.0K | +$3M | $3M |
| ADBEADOBE SYSTEMS INCORPORATED | NEW | +10.0K | 10.0K | +$3M | $3M |
| CHEMOCENTRYX INC | NEW | +50.0K | 50.0K | +$3M | $3M |
| SNOWSNOWFLAKE INC | NEW | +15.0K | 15.0K | +$3M | $3M |
| STORE CAP CORP | NEW | +55.0K | 55.0K | +$2M | $2M |
| ARANTERO RESOURCES CORP | NEW | +50.0K | 50.0K | +$2M | $2M |
| VRTXVERTEX PHARMACEUTICALS INC | NEW | +5.0K | 5.0K | +$1M | $1M |
| ATLAS CORP | NEW | +72.8K | 72.8K | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | BRIACELL THERAPEUTICS CORP | COM NEW | 7.35% | $7M | 1.20M |
| 2 | AMERICAS GOLD AND SILVER COR | COM | 3.77% | $3M | 7.94M |
| 3 | GDXJVANECK ETF TRUSThistory → | JUNIOR GOLD MINE | 3.22% | $3M | 100.0K |
| 4 | PEARL HOLDINGS ACQUISITN COR | CLASS A ORD SHS · *W EXP 12/15/202 | 3.21% | $3M | 325.0K |
| 5 | ADBEADOBE SYSTEMS INCORPORATEDhistory → | COM | 3.00% | $3M | 10.0K |
| 6 | LAKESHORE ACQUISITION I CORP | ORDINARY SHARES · *W EXP 07/15/202 | 2.94% | $3M | 291.4K |
| 7 | CHEMOCENTRYX INC | COM | 2.82% | $3M | 50.0K |
| 8 | SNOWSNOWFLAKE INChistory → | CL A | 2.78% | $3M | 15.0K |
| 9 | ROTH CH ACQUISITION IV CO | COM · *W EXP 07/01/202 | 2.52% | $2M | 278.9K |
| 10 | SPORTSMAP TECH ACQUISITIN CO | COM · UNIT 09/01/2027 · *W EXP 09/01/202 | 2.31% | $2M | 252.4K |
| 11 | BATTERY FUTURE ACQUISITION C | CL A ORD SHS · *W EXP 99/99/999 | 2.21% | $2M | 240.3K |
| 12 | DECARBONIZATION PLUS ACQUISI | COM CL A · *W EXP 07/15/202 | 1.95% | $2M | 215.5K |
| 13 | STORE CAP CORP | COM | 1.88% | $2M | 55.0K |
| 14 | LEGATO MERGER CORP II | COM · *W EXP 09/01/202 | 1.83% | $2M | 197.8K |
| 15 | WORLD QUANTUM GROWTH ACQUISI | SHS CL A · *W EXP 08/04/202 | 1.72% | $2M | 201.9K |
| 16 | ARANTERO RESOURCES CORPhistory → | COM | 1.67% | $2M | 50.0K |
| 17 | EXECUTIVE NETWORK PARTNERING | CL A | 1.63% | $1M | 150.0K |
| 18 | VRTXVERTEX PHARMACEUTICALS INChistory → | COM | 1.58% | $1M | 5.0K |
| 19 | TARGET GLOBAL ACQUISI I CORP | CLASS A ORD SHS · *W EXP 12/08/202 | 1.52% | $1M | 161.0K |
| 20 | IG ACQUISITION CORP | COM CL A | 1.38% | $1M | 126.3K |
| 21 | DENALI CAPITAL ACQUISITN COR | CLASS A ORD · *W EXP 03/28/202 | 1.27% | $1M | 219.5K |
| 22 | THE GROWTH FOR GOOD ACQU COR | CLASS A ORD SHS · RIGHT 11/12/2026 · *W EXP 11/12/202 | 1.24% | $1M | 165.0K |
| 23 | ROC ENERGY ACQUISITION CORP | COMMON STOCK · RIGHT 11/30/2028 | 1.18% | $1M | 132.5K |
| 24 | ANTHEMIS DIGITAL ACQUISITION | CLASS A ORD · *W EXP 11/01/202 | 1.16% | $1M | 126.4K |
| 25 | FINNOVATE ACQUISITION CORP | CLASS A ORD SHS · *W EXP 09/30/202 | 1.16% | $1M | 130.5K |
| 26 | FTAC ATHENA ACQUISITION CORP | CL A SHS | 1.15% | $1M | 106.2K |
| 27 | JACKSON ACQUISITION CO | COM CL A · *W EXP 99/99/999 | 1.15% | $1M | 135.5K |
| 28 | MERCATO PARTNERS ACQUISITION | CLASS A COM · *W EXP 99/99/999 | 1.12% | $1M | 137.0K |
| 29 | EVE MOBILITY ACQUISITION COR | CL A ORD SHS · *W EXP 12/31/202 | 1.11% | $1M | 129.1K |
| 30 | ATLAS CORP | SHARES | 1.11% | $1M | 72.8K |
| 31 | ANDRETTI ACQUISITION CORP | CL A ORD SHS · *W EXP 99/99/999 | 1.10% | $1M | 125.0K |
| 32 | PORTWSOUTHPORT ACQUISITION CORP | CL A COM · *W EXP 99/99/999 | 1.10% | $1M | 126.3K |
| 33 | VMG CONSUMER ACQUISITION COR | CLASS A COM · *W EXP 11/03/202 | 1.10% | $1M | 124.9K |
| 34 | VY GLOBAL GROWTH | COM CL A | 1.10% | $1M | 100.4K |
| 35 | AURA FAT PROJS ACQUISITION C | CLASS A ORD · *W EXP 03/31/202 | 1.10% | $1M | 194.0K |
| 36 | MOTIVE CAPITAL CORP II | CL A ORD · *W EXP 99/99/999 | 1.09% | $999,000 | 105.0K |
| 37 | FAR PEAK ACQUISITION CORP | SHS CL A | 1.03% | $940,000 | 95.0K |
| 38 | MOUNTAIN & CO I ACQUISITN CO | CLASS A ORD · *W EXP 09/30/202 | 1.01% | $923,000 | 120.0K |
| 39 | XBISPDR SER TR | S&P BIOTECH | 0.95% | $872,000 | 11.0K |
| 40 | BLEUACACIA LTD | CLASS A ORD SHS | 0.90% | $827,000 | 83.9K |
| 41 | TALON 1 ACQUISITION CORP | CLASS A ORD · *W EXP 07/30/202 | 0.89% | $816,000 | 100.0K |
| 42 | OYSTER ENTERPRISES ACQ CORP | COM CL A | 0.85% | $781,000 | 79.1K |
| 43 | RF ACQUISITION CORP | CLASS A COM · RIGHT 05/01/2028 · *W EXP 05/01/202 | 0.85% | $779,000 | 198.2K |
| 44 | ZENDESK INC | COM | 0.83% | $761,000 | 10.0K |
| 45 | APX ACQUISITION CORP I | CLASS A ORD SHS · *W EXP 11/30/202 | 0.83% | $760,000 | 87.9K |
| 46 | LIV CAPITAL ACQUISITN CORP I | CLASS A ORD SHS · *W EXP 02/07/202 | 0.83% | $759,000 | 114.4K |
| 47 | AP ACQUISITION CORP | CL A ORD SHS | 0.78% | $712,000 | 70.0K |
| 48 | ADIT EDTECH ACQUISITION CORP | COMMON STOCK | 0.78% | $712,000 | 72.0K |
| 49 | G&P ACQUISITION CORP | COM CL A | 0.75% | $686,000 | 68.6K |
| 50 | MAIAMAIA BIOTECHNOLOGY INC | COM | 0.72% | $659,000 | 199.8K |
| 51 | UTA ACQUISITION CORPORATION | CLASS A ORD SHS · *W EXP 10/30/202 | 0.71% | $654,000 | 80.0K |
| 52 | PURPLE INNOVATION INC | COM | 0.71% | $648,000 | 160.0K |
| 53 | TAILWIND INTERNATNAL ACQ COR | COM CL A | 0.69% | $635,000 | 64.0K |
| 54 | ANZU SPECIAL ACQUISITIN CORP | COM CL A | 0.68% | $623,000 | 63.4K |
| 55 | DTRT HEALTH ACQUISITION CORP | COM CL A · *W EXP 08/31/202 | 0.67% | $610,000 | 76.0K |
| 56 | SIGNIFY HEALTH INC | CL A COM | 0.64% | $583,000 | 20.0K |
| 57 | JUNIPER II CORP | CL A COM · *W EXP 99/99/999 | 0.63% | $577,000 | 71.4K |
| 58 | ASANASANA INC | CL A | 0.61% | $556,000 | 25.0K |
| 59 | TG VENTURE ACQUISITION CORP | CLASS A COM · *W EXP 08/15/202 | 0.60% | $552,000 | 76.5K |
| 60 | IBERE PHARMACEUTICALS | SHS CL A · *W EXP 03/01/202 | 0.56% | $510,000 | 61.2K |
| 61 | ROCKET LAB USA INC | COM | 0.56% | $509,000 | 125.0K |
| 62 | FG MERGER CORP | COMMON STOCK · *W EXP 06/17/202 | 0.55% | $506,000 | 80.0K |
| 63 | ST ENERGY TRANSITION I LTD | CL A ORD SHS | 0.55% | $502,000 | 50.1K |
| 64 | MUMICRON TECHNOLOGY INC | COM | 0.55% | $501,000 | 10.0K |
| 65 | VVISA INC | COM CL A | 0.48% | $444,000 | 2.5K |
| 66 | HEALTHCARE AI ACQUISITION CO | CLASS A ORD SHS | 0.46% | $418,000 | 41.5K |
| 67 | TRANSGLOBE ENERGY CORP | COM | 0.44% | $402,000 | 150.0K |
| 68 | PHOENIX BIOTECH ACQUISITION | CLASS A COM | 0.44% | $400,000 | 39.6K |
| 69 | MISSION ADVANCEMENT CORP | CL A | 0.38% | $344,000 | 35.0K |
| 70 | HORIZON ACQUISITION CORPORAT | SHS CL A | 0.37% | $339,000 | 33.9K |
| 71 | INTELLIGENT MEDI ACQSITN COR | CLASS A COM | 0.35% | $317,000 | 31.5K |
| 72 | EVCOEVEREST CONSOLIDATOR ACQ COR | CL A COM | 0.34% | $313,000 | 31.1K |
| 73 | ROTH CH ACQUISITION V CO | COM · *W EXP 12/10/202 | 0.33% | $304,000 | 40.4K |
| 74 | BLOCKCHAIN COINVSTRS ACQ CRP | CLASS A ORD · *W EXP 11/01/202 | 0.33% | $304,000 | 42.5K |
| 75 | LIVE OAK MOBILITY ACQUISI CO | COM CL A | 0.32% | $295,000 | 30.0K |
| 76 | BLUBELLUS HEALTH INC NEW | COM NEW | 0.29% | $264,000 | 25.0K |
| 77 | SEMPER PARATUS ACQUISITION C | CLASS A ORD | 0.29% | $263,000 | 25.9K |
| 78 | ATLAS CREST INVESTMENT CORP | COM CL A | 0.28% | $255,000 | 25.8K |
| 79 | INVESTCORP EUROPE ACQUISITIO | CLASS A ORD SHS | 0.28% | $253,000 | 25.0K |
| 80 | LF CAPITAL ACQUISITION CORP | CLASS A COM | 0.28% | $252,000 | 25.0K |
| 81 | SIZZLE ACQUISITION CORP | COMMON STOCK | 0.28% | $252,000 | 25.0K |
| 82 | BLACK MOUNTAIN ACQ CORP | CL A COM | 0.27% | $251,000 | 25.0K |
| 83 | APEIRON CAPITAL INVEST CORP | CL A COM | 0.27% | $251,000 | 25.1K |
| 84 | BIOPLUS ACQUISITION CORP | CLASS A ORD SHS | 0.27% | $251,000 | 25.0K |
| 85 | PROOF ACQUISITION CORP I | CL A COM | 0.27% | $250,000 | 25.0K |
| 86 | FOREST ROAD ACQUISITION COR | CL A | 0.27% | $250,000 | 25.5K |
| 87 | COVA ACQUISITION CORP | CL A SHS | 0.27% | $249,000 | 25.0K |
| 88 | FUSION ACQUISITION CORP II | COM CL A | 0.27% | $246,000 | 25.0K |
| 89 | HUNT COMPANIES ACQUISITIO | CL ACOM | 0.23% | $207,000 | 20.4K |
| 90 | SOUND POINT ACQUISITION CORP | CLASS A ORD SHS | 0.22% | $204,000 | 20.0K |
| 91 | SVXYPROSHARES TR II | SHT VIX ST TRM | 0.16% | $146,000 | 3.0K |
| 92 | INNOVATIVE INTL ACQUSITIN CO | CLASS A ORD | 0.15% | $139,000 | 13.7K |
| 93 | CARTICA ACQUISITION CORP | CLASS A ORD SHS | 0.15% | $133,000 | 13.2K |
| 94 | TKB CRITICAL TECHNOLOGIES 1 | CLASS A ORD | 0.13% | $120,000 | 11.8K |
| 95 | EONRHNR ACQUISITION CORP | COM | 0.11% | $104,000 | 10.3K |
| 96 | PERCEPTION CAPITAL CORP II | CLASS A ORD | 0.11% | $102,000 | 10.0K |
| 97 | KIMBELL TIGER ACQUISITION CO | COM CL A | 0.11% | $101,000 | 10.0K |
| 98 | ACCRETION ACQUISITION CORP | COM | 0.11% | $99,000 | 10.0K |
| 99 | FLAME ACQUISITION CORP | COM CL A | 0.11% | $98,000 | 10.0K |
| 100 | GORES TECHNOLOGY PARTNERS II | CLASS A COM | 0.11% | $98,000 | 10.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2024 | $17M | 57 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $23M | 56 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $38M | 72 | Nov 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $79M | 111 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 129 | May 15, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2022 | Under review | 131 | Feb 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $92M | 146 | Oct 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $90M | 144 | Aug 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $93M | 139 | May 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $105M | 112 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.